Navigation Links
Cipro Has Cheaper Cousins to Treat Anthrax

Cipro, Cipro, Cipro. That's been the mantra of the media as dozens of people exposed to anthrax -- and thousands who weren't -- clamor for the potent antibiotic. But if the supply dwindles, doctors say other cheaper and widely available medications can be used, including a previous generation's wonder drug: penicillin. Although alternatives exist, Cipro is the latest and greatest, so it tends to get attention. //

It helped that Cipro was the only drug approved by the Food and Drug Administration to treat inhaled anthrax. But Health and Human Services Secretary Tommy Thompson today encouraged the use of two other antibiotics, penicillin and doxycycline. Before this month, Cipro -- the brand name for the drug ciprofloxacin -- was little known outside of doctor's offices and pharmacies, where it is dispensed to treat a variety of diseases, including urinary tract infections.

Like other antibiotics, Cipro kills harmful bacteria in the body. The main difference is that it's designed to attack a variety of types of germs. It is effective against a wide range of organisms. Doctors sometimes use Cipro when they are waiting to find out exactly what type of bacteria they're dealing with. It's especially effective against anthrax because it may take days for scientists to discover what kind of strain is involved in an attack.

According to experts, all known strains are vulnerable to Cipro, although the drug must be given before symptoms develop or shortly thereafter to be most effective. Before Cipro came along, penicillin was a common treatment for anthrax. Pharmaceutical companies say they're ready to ramp up production of anti-anthrax drugs if needed.


Page: 1

Related medicine news :

1. Once-Daily Cipro(R) XR for Treating Complicated Urinary Tract Infections
2. Small Cars, Anti-AIDS And Anti-Cancer Drugs Would Be Cheaper
3. Cheaper Vaccines From Tomatoes To Fight HIV, Hepatitis B
4. Diabetics to get Relief from Cheaper Drugs
5. Cheaper and Quicker Alternative to Ovarian Reserve Tests
6. Cousins Recovering from His Substance Abuse Problem
7. Advances in Treatment of Cataracts
8. Recommendations for Treatment of Blood Pressue
9. New FDA Approved Drug To Treat Migraine
10. Treatment for Menieres disease
11. Treatment for pre-menstrual syndrome is ineffective
Post Your Comments:

(Date:6/26/2016)... ... June 26, 2016 , ... Many ... been diagnosed with endometriosis. These women need a treatment plan to not only ... approach that can help for preservation of fertility and ultimately achieving a pregnancy. ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented ... in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
(Date:6/23/2016)... WAYNE, Pa. , June 23, 2016 ... provider, will launch its next generation clinical outcomes platform, Bracket ... DIA Meeting held on June 26 – 30, 2016 in ... 6.0, the first electronic Clinical Outcome Assessment product of its ... DIA Booth #715. Bracket eCOA 6.0 is a ...
Breaking Medicine Technology: